Research
Energy balance
Semaglutide has been shown to result in a loss of almost 12% of body weight over a 68-week period.
Semaglutide can be considered an effective option for significant weight loss in eligible patients.
StrongSupportsmedium confidence
Manufacturer-sponsored randomised controlled trials have shown a loss of almost 12% of body weight over a 68-week period.
Why this rating
Based on manufacturer-sponsored randomised controlled trials.
Source
Semaglutide: a new drug for the treatment of obesity
Joel Lexchin et al. · Drug and Therapeutics Bulletin · 2023
DOI 10.1136/dtb.2023.000007
otherCited 18×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →